AI-driven Clinical Decision Support to Reduce Hospital-Acquired Venous Thromboembolism: Study Protocol for the VTE-AI Randomized Trial.

NANot yet recruitingINTERVENTIONAL
Enrollment

2,236

Participants

Timeline

Start Date

October 1, 2025

Primary Completion Date

September 30, 2026

Study Completion Date

March 31, 2027

Conditions
Venothromboembolism
Interventions
OTHER

Risk model-driven CDS

"The CDS intervention will use an automated risk model called VTE-AI to add EHR-based prompts in the form of alerts targeting those encounters on which 1) VTE-AI risk is above 5% predicted risk (found to be high risk in prior analyses), 2) no active DVT prophylaxis pharmacologic order is present, 3) no contraindication has been documented in the current admission"

All Listed Sponsors
lead

Vanderbilt University Medical Center

OTHER

NCT06939803 - AI-driven Clinical Decision Support to Reduce Hospital-Acquired Venous Thromboembolism: Study Protocol for the VTE-AI Randomized Trial. | Biotech Hunter | Biotech Hunter